Iberdomide

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameIberdomide
Drug Alias NameIBERIbderomideCC-220BMS-986382BMS 986382
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionZinc finger protein Aiolos degradersDNA-binding protein Ikaros degraders
TargetsDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsLupus Erythematosus, SystemicSarcoidosisRenal Insufficiency +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[39] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb (China) Investment Co LtdUniversity College London +[14] 
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicRenal InsufficiencySmoldering Multiple Myeloma +[5] 
Inactive IndicationsSarcoidosisHepatic InsufficiencyLymphoma

Other Information

ATC CodeN/A
Related LinksN/A